Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global epidemiology of lean non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
Feng‐Bin Lu, Kenneth I. Zheng, Rafael S. Rios, et al.
Journal of Gastroenterology and Hepatology (2020) Vol. 35, Iss. 12, pp. 2041-2050
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
Mary E. Rinella, Brent A. Neuschwander‐Tetri, Mohammad Shadab Siddiqui, et al.
Hepatology (2023) Vol. 77, Iss. 5, pp. 1797-1835
Open Access | Times Cited: 1100
AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review
Zobair M. Younossi, Kathleen E. Corey, Joseph K. Lim
Gastroenterology (2020) Vol. 160, Iss. 3, pp. 912-918
Closed Access | Times Cited: 351
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis
Jingxuan Quek, Kai En Chan, Zhen Yu Wong, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 8, Iss. 1, pp. 20-30
Closed Access | Times Cited: 326
Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight
Mohammed Eslam, Hashem B. El‐Serag, Sven Francque, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 10, pp. 638-651
Closed Access | Times Cited: 159
Review article: the epidemiologic burden of non‐alcoholic fatty liver disease across the world
Linda Henry, James M. Paik, Zobair M. Younossi
Alimentary Pharmacology & Therapeutics (2022) Vol. 56, Iss. 6, pp. 942-956
Closed Access | Times Cited: 137
Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis
Ansel Shao Pin Tang, Cheng Han Ng, Poh Hui Phang, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 21, Iss. 7, pp. 1750-1760.e12
Closed Access | Times Cited: 75
Epidemiology of Metabolic Dysfunction Associated Steatotic Liver Disease
Zobair M. Younossi, Markos Kalligeros, Linda Henry
Clinical and Molecular Hepatology (2024)
Open Access | Times Cited: 26
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Marco Arrese, Juan Pablo Arab, Francisco Barrera, et al.
Seminars in Liver Disease (2021) Vol. 41, Iss. 04, pp. 421-434
Open Access | Times Cited: 75
Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges
Mohammad Shafi Kuchay, José Ignacio Martínez‐Montoro, Narendra S. Choudhary, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1346-1346
Open Access | Times Cited: 72
Emerging Role of Genomic Analysis in Clinical Evaluation of Lean Individuals With NAFLD
Sílvia Vilarinho, Veeral Ajmera, Melanie Zheng, et al.
Hepatology (2021) Vol. 74, Iss. 4, pp. 2241-2250
Open Access | Times Cited: 66
PM2.5 air pollution exposure and nonalcoholic fatty liver disease in the Nationwide Inpatient Sample
Trang VoPham, Nicole J. Kim, Kristin Berry, et al.
Environmental Research (2022) Vol. 213, pp. 113611-113611
Open Access | Times Cited: 52
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)
Ajay Duseja, Shivaram Prasad Singh, Arka De, et al.
Journal of Clinical and Experimental Hepatology (2022) Vol. 13, Iss. 2, pp. 273-302
Open Access | Times Cited: 47
Nonalcoholic fatty liver disease: Current therapies and future perspectives in drug delivery
Inês Domingues, Isabelle Leclercq, Ana Beloqui
Journal of Controlled Release (2023) Vol. 363, pp. 415-434
Closed Access | Times Cited: 27
Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ‐ prevalence, clinical impact, economic implications and management strategies
Pegah Golabi, Soroor Owrangi, Zobair M. Younossi
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. S1
Open Access | Times Cited: 13
Lifestyle intervention for metabolic dysfunction-associated fatty liver disease: a 24-h integrated behavior perspective
Shelley E. Keating, Yogesh Chawla, Arka De, et al.
Hepatology International (2024) Vol. 18, Iss. S2, pp. 959-976
Open Access | Times Cited: 7
Nonalcoholic Fatty Liver Disease: A Global Perspective
Wei‐Kei Wong, Wah‐Kheong Chan
Clinical Therapeutics (2021) Vol. 43, Iss. 3, pp. 473-499
Open Access | Times Cited: 47
Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study
Eunice Tan, Jonathan Lee, Nur Halisah Binte Jumat, et al.
Metabolism (2021) Vol. 126, pp. 154911-154911
Open Access | Times Cited: 46
Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction‐associated fatty liver disease
Wah‐Kheong Chan, Soek‐Siam Tan, Siew‐Pheng Chan, et al.
Journal of Gastroenterology and Hepatology (2022) Vol. 37, Iss. 5, pp. 795-811
Open Access | Times Cited: 34
Nonalcoholic Fatty Liver Disease: Current Global Burden
Mohamed El‐Kassas, Joaquín Cabezas, Paula Iruzubieta, et al.
Seminars in Liver Disease (2022) Vol. 42, Iss. 03, pp. 401-412
Closed Access | Times Cited: 32
Lean MASLD and Cardiovascular Disease: A Review
Nachum Lebovics, Gabriel Heering, William H. Frishman, et al.
Cardiology in Review (2025)
Closed Access
Sleep Duration, Sleep Quality, and the Development of Nonalcoholic Fatty Liver Disease: A Cohort Study
Yoo Jin Um, Yoosoo Chang, Hyun Suk Jung, et al.
Clinical and Translational Gastroenterology (2021) Vol. 12, Iss. 10, pp. e00417-e00417
Open Access | Times Cited: 39
New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis
Georgiana-Diana Cazac, C.M. Lǎcǎtusu, Cătălina Mihai, et al.
Life (2022) Vol. 12, Iss. 8, pp. 1189-1189
Open Access | Times Cited: 23
Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment
Ankoor Patel, Dhiraj Peddu, Sahil Amin, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 22
Special Population
Ajay Duseja, Arka De, Vincent Wai‐Sun Wong
Clinics in Liver Disease (2023) Vol. 27, Iss. 2, pp. 451-469
Closed Access | Times Cited: 14
Association of long-term ambient fine particulate matter (PM2.5) and incident non-alcoholic fatty liver disease in Chinese adults
Peizhi Deng, Haibo Tang, Liyong Zhu, et al.
Environmental Pollution (2023) Vol. 329, pp. 121666-121666
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top